Intelicanna Ltd (INTL) - Cash Flow Conversion Efficiency

Latest as of December 2022: -0.025x

Based on the latest financial reports, Intelicanna Ltd (INTL) has a cash flow conversion efficiency ratio of -0.025x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-194.89 Million ≈ $-522.48K USD) by net assets (ILA7.77 Billion ≈ $20.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Intelicanna Ltd (INTL) balance sheet quality index to measure how much of total assets are equity-financed.

Intelicanna Ltd - Cash Flow Conversion Efficiency Trend (2012–2022)

This chart illustrates how Intelicanna Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check INTL operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Intelicanna Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Intelicanna Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Indal Aluminium Industry Tbk JK:INAI	0.399x
TG-17, Inc. Common Stock NASDAQ:OBAI	0.161x
TNF Pharmaceuticals, Inc. NASDAQ:TNFA	-0.178x
Auction Technology Group PLC LSE:ATG	0.052x
Nelson Resources Ltd AU:NES	-0.099x
ECS Botanics Holdings Ltd AU:ECS	0.015x
Openn Negotiation Ltd AU:OPN	0.905x
FAST TRACK GROUP NASDAQ:FTRK	-0.460x

Annual Cash Flow Conversion Efficiency for Intelicanna Ltd (2012–2022)

The table below shows the annual cash flow conversion efficiency of Intelicanna Ltd from 2012 to 2022. For the full company profile with market capitalisation and key ratios, see Intelicanna Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2022-12-31	ILA7.77 Billion ≈ $20.84 Million	ILA-286.06 Million ≈ $-766.91K	-0.037x	-166.91%
2021-12-31	ILA6.78 Billion ≈ $18.17 Million	ILA372.78 Million ≈ $999.41K	0.055x	+110.63%
2020-12-31	ILA7.04 Billion ≈ $18.88 Million	ILA-3.64 Billion ≈ $-9.77 Million	-0.518x	-2543.55%
2019-12-31	ILA8.07 Billion ≈ $21.64 Million	ILA-158.05 Million ≈ $-423.74K	-0.020x	+91.86%
2018-12-31	ILA7.19 Billion ≈ $19.28 Million	ILA-1.73 Billion ≈ $-4.64 Million	-0.240x	-63.55%
2017-12-31	ILA6.87 Billion ≈ $18.42 Million	ILA-1.01 Billion ≈ $-2.71 Million	-0.147x	-581.67%
2016-12-31	ILA5.99 Billion ≈ $16.07 Million	ILA182.92 Million ≈ $490.39K	0.031x	+106.88%
2015-12-31	ILA4.91 Billion ≈ $13.17 Million	ILA-2.18 Billion ≈ $-5.84 Million	-0.444x	+24.51%
2014-12-31	ILA4.89 Billion ≈ $13.12 Million	ILA-2.88 Billion ≈ $-7.71 Million	-0.588x	-1336.24%
2013-12-31	ILA4.41 Billion ≈ $11.84 Million	ILA-180.63 Million ≈ $-484.25K	-0.041x	+58.50%
2012-12-31	ILA33.29 Billion ≈ $89.24 Million	ILA-3.28 Billion ≈ $-8.80 Million	-0.099x	--

About Intelicanna Ltd

TA:INTL Israel Drug Manufacturers - Specialty & Generic

Market Cap

$6.79 Million

ILA2.53 Billion ILA

Market Cap Rank

#27957 Global

#405 in Israel

Share Price

ILA53.90

Change (1 day)

+3.65%

52-Week Range

ILA45.50 - ILA114.90

All Time High

ILA11460.00